arger time-frames and thereby result in inadequate supply of the necessary vaccines in case of a sudden pandemic attack. New strains of viruses resulting from antigenic shift of the A/California/7/2009 (H1N1)pdm09 virus, usually occurring when the virus is being passed on from animal to animal or a human being, also stresses the need to develop more effective vaccines. However, manufacturers face a daunting challenge in the form of the huge costs involved in vaccine development, clinical trials, regulatory approval, mass production, and commercialization.
North America accounts for the largest share of H1N1 vaccine sales worldwide, as stated by the new market research report on H1N1 Vaccines. Rapid growth in birth cohorts in developing countries, coupled with the improvement in access to public and private healthcare and increased spending, entail a growing demand for vaccines in the developing world. Notably, the 2009 H1N1 pandemic resulted in widespread panic in China and India, partly due to the respective government’s unpreparedness to handle the disease outbreak. The governments in these countries are expected to continue domestic production and stockpiling of reserve H1N1 vaccine doses in the near term. Increasing public awareness about influenza vaccines, coupled with the need to safeguard the population in the event of a future outbreak, will continue to drive sales of H1N1 vaccines.
Key players covered in the report include Baxter International Inc., CPL Biologicals Pvt. Ltd., CSL Limited, bioCSL, GlaxoSmithKline Plc., MedImmune LLC, Novartis AG, Sanofi Pasteur SA, Sinovac Biotech Ltd., and Zydus Cadilla.
The research report titled “H1N1 Vaccines: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides an in-depth study of the key factors influencing the performance of H1N1 influenza va
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. ResearchMoz.us: RFID Blood Monitoring Systems (Blood Refrigerators and Freezers) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 20192
. Global Adhesives and Sealants Market 2012-2016 - Worldwide Industry Growth, Opportunity, Players, Size And Forecast Research Report Available Online3
. Global Lung Cancer Therapeutics Market 2013 Report Featuring Leading Players Such As AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline, Hoffmann-La Roche, Novartis And Others4
. The Global Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 Billion by 2017 Says Latest Report5
. The Global Surgical Equipment Market to Grow At A CAGR Of 6.25 Percent over the Period 2012-20166
. Global Crop Protection Chemicals Market Till 2016 - Worldwide Research Report, Industry Share, Size, Trends, Analysis, Growth and Forecast 2012-2016: MarketResearchReports7
. Environmental Concerns & Depleting Fossil Fuels Drive the Global Renewable Chemicals Market, According to New Report by Global Industry Analysts, Inc.8
. Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 20189
. In Vitro Diagnostics Market is Expected to Reach USD 74.2 Billion Globally in 2018: Transparency Market Research10
. Pain Management Therapeutics Market is Expected to Decline to USD 29.47 Billion Globally by 2018: Transparency Market Research11
. RFID Blood Monitoring Systems (Blood Refrigerators and Freezers) Market is Expected to Reach USD 174.2 Million Globally in 2019: Transparency Market Research